To investigate the efficacy and safety of fingolimod (FTY) 0.5 mg administered every other day (FTY-EOD) compared to every day (FTY-ED) in multiple sclerosis patients.
Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational study
PATTI, Francesco;
2018-01-01
Abstract
To investigate the efficacy and safety of fingolimod (FTY) 0.5 mg administered every other day (FTY-EOD) compared to every day (FTY-ED) in multiple sclerosis patients.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Multiple Sclerosis 2018.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
192.98 kB
Formato
Adobe PDF
|
192.98 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
